tiprankstipranks
Aridis Pharmaceuticals (ARDS)
OTHER OTC:ARDS
US Market

Aridis Pharmaceuticals (ARDS) Technical Analysis

206 Followers

Summary of all the Indicators

Overall Consensus
Sell
4Bullish
4Neutral
13Bearish
Technical Analysis Consensus
Buy
3Bullish
4Neutral
2Bearish
Moving Average Consensus
Strong Sell
1Bullish
0Neutral
11Bearish
Aridis Pharmaceuticals’s (ARDS) Moving Averages Convergence Divergence (MACD) indicator is >-0.01, suggesting Aridis Pharmaceuticals is a Sell.
Aridis Pharmaceuticals’s (ARDS) 20-Day exponential moving average is 0.06, while Aridis Pharmaceuticals’s (ARDS) share price is <$0.1, making it a Sell.
Aridis Pharmaceuticals’s (ARDS) 50-Day exponential moving average is 0.07, while Aridis Pharmaceuticals’s (ARDS) share price is <$0.1, making it a Sell.

Aridis Pharmaceuticals (ARDS) Pivot Points

May 17, 2024, 11:38 PM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
0.04
0.05
0.05
0.06
0.07
0.07
0.08
Fibonacci
0.05
0.05
0.06
0.06
0.06
0.07
0.07
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Aridis Pharmaceuticals (ARDS) Moving Averages

May 17, 2024, 11:38 PM
Period
Simple
Exponential
MA5
0.06Buy
0.06Sell
MA10
0.06Sell
0.06Sell
MA20
0.06Sell
0.06Sell
MA50
0.07Sell
0.07Sell
MA100
0.07Sell
0.07Sell
MA200
0.08Sell
0.11Sell
Aridis Pharmaceuticals’s (ARDS) 10-Day exponential moving average is 0.06, while Aridis Pharmaceuticals’s (ARDS) share price is <$0.1, making it a Sell.
Aridis Pharmaceuticals’s (ARDS) 100-Day exponential moving average is 0.07, while Aridis Pharmaceuticals’s (ARDS) share price is <$0.1, making it a Sell.
Aridis Pharmaceuticals’s (ARDS) stock price is <$0.1 and Aridis Pharmaceuticals’s (ARDS) 50-day simple moving average is 0.07, creating a Sell signal.
Aridis Pharmaceuticals’s (ARDS) stock price is <$0.1 and Aridis Pharmaceuticals’s (ARDS) 100-day simple moving average is 0.07, creating a Sell signal.
Aridis Pharmaceuticals’s (ARDS) stock price is <$0.1 and Aridis Pharmaceuticals’s (ARDS) 200-day simple moving average is 0.08, creating a Sell signal.

Aridis Pharmaceuticals (ARDS) Technical Indicators

May 17, 2024, 11:38 PM
Name
Value
Implied Action
RSI (14)
43.14
Neutral
STOCH (9,6)
36.75
Neutral
STOCHRSI (14)
36.75
Neutral
MACD (12,26)
>-0.01
Sell
ADX (14)
15.27
Buy
Williams %R
-61.54
Buy
CCI (14)
-130.08
Buy
ATR (14)
<0.01
-
Ultimate Oscillator
38.62
Neutral
ROC
0.00
-
Aridis Pharmaceuticals’s (ARDS) Relative Strength Index (RSI) is 43.14, creating a Neutral signal.
Aridis Pharmaceuticals’s (ARDS) Trend Strength Indicator (ADX) is 15.27, creating a Buy signal.
Aridis Pharmaceuticals’s (ARDS) Commodity Channel Index (CCI) is -130.08, creating a Buy signal.

FAQ

Is ARDS a Buy, Hold, or Sell?
Based on ARDS’s technical indicators, ARDS is a Sell.
    What is ARDS’s RSI (14)?
    ARDS’s RSI (14) is 43.14, which suggests ARDS is a Neutral.
      What is ARDS’s MACD?
      ARDS’s MACD is >-0.01, which suggests ARDS is a Sell.
        What is ARDS’s 5-day moving average?
        ARDS’s 5-day moving average is 0.06, which suggests ARDS is a Buy.
          What is ARDS’s 20-day moving average?
          ARDS 20-day moving average is 0.06, which suggests ARDS is a Sell.
            What is ARDS’s 50-day moving average?
            ARDS’s 50-day moving average is 0.07, which suggests ARDS is a Sell.
              What is ARDS’s 200-day moving average?
              ARDS’s 200-day moving average is 0.08, which suggests ARDS is a Sell.
                What is ARDS’s Williams % R (14)?
                ARDS’s Williams % R (14) is -61.54, which suggests ARDS is a Buy.
                  What is ARDS’s CCI (14)?
                  ARDS’s CCI (14) is -130.08, which suggests ARDS is a Buy.
                    What's Included in PREMIUM?
                    Make informed decisions based on Top Analysts' activity
                    Know what industry insiders are buying
                    Get actionable alerts from top Wall Street Analysts
                    Find out before anyone else which stock is going to shoot up
                    Get powerful stock screeners & detailed portfolio analysis